These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7727857)

  • 61. Understanding of the molecular basis of drug resistance in cancer reveals new targets for chemotherapy.
    Dickson RB; Gottesman MM
    Trends Pharmacol Sci; 1990 Aug; 11(8):305-7. PubMed ID: 2203190
    [No Abstract]   [Full Text] [Related]  

  • 62. Modulation of multidrug resistance: at the threshold.
    Sikic BI
    J Clin Oncol; 1993 Sep; 11(9):1629-35. PubMed ID: 8355032
    [No Abstract]   [Full Text] [Related]  

  • 63. [Resistance of neoplasms to chemotherapy].
    Cerný V
    Nowotwory; 1978; 28(1):39-50. PubMed ID: 662714
    [No Abstract]   [Full Text] [Related]  

  • 64. Chemotherapeutic failure: resistance or insensitivity?
    Braverman AS
    Ann Intern Med; 1993 Apr; 118(8):630-2. PubMed ID: 8452329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug resistance: the clinical problem.
    Young RC
    Cancer Treat Res; 1989; 48():1-12. PubMed ID: 2577131
    [No Abstract]   [Full Text] [Related]  

  • 66. [Drug resistance: from research to clinical trial. XIth meeting of Grenobloises de Cancérologie. 24-25 March 1994].
    Bull Cancer; 1994 Dec; 81 Suppl 2():51s-117s. PubMed ID: 7727858
    [No Abstract]   [Full Text] [Related]  

  • 67. A stochastic model of the acquisition of drug resistance during antineoplastic chemotherapy.
    Abundo M; Rossi C; Benassi M; Gentile FP; Mauro F
    Health Phys; 1989; 57 Suppl 1():349-54. PubMed ID: 2606692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stemming the tide of drug resistance in cancer.
    Mullard A
    Nat Rev Drug Discov; 2020 Apr; 19(4):221-223. PubMed ID: 32203291
    [No Abstract]   [Full Text] [Related]  

  • 69. Multidrug resistance in cancers of childhood: clinical relevance and circumvention.
    Chan HS; Thorner PS; Haddad G; DeBoer G; Gallie BL; Ling V
    Adv Pharmacol; 1993; 24():157-97. PubMed ID: 8504063
    [No Abstract]   [Full Text] [Related]  

  • 70. Mathematical modeling for tumor resistance.
    Kuczek T; Chan TC
    J Natl Cancer Inst; 1988 Apr; 80(3):146-7. PubMed ID: 3346908
    [No Abstract]   [Full Text] [Related]  

  • 71. [Development of antitumor drugs: current and future situation].
    Cortés-Funes H
    Rev Clin Esp; 1987 Nov; 181(8):407-9. PubMed ID: 3326067
    [No Abstract]   [Full Text] [Related]  

  • 72. Response rates--an evolution.
    Poplin E; Baker L
    Cancer Chemother Pharmacol; 1994; 34(4):361-3. PubMed ID: 8033304
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Optimal chemical control of populations developing drug resistance.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1992; 9(3):215-26. PubMed ID: 1295929
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Resistance testing of malignant tumors].
    Volm M; Ehrhart H
    MMW Munch Med Wochenschr; 1977 Mar; 119(9):Suppl. 7-8. PubMed ID: 403459
    [No Abstract]   [Full Text] [Related]  

  • 75. Some aspects of drug resistance in neoplasms.
    LAW LW
    Ann N Y Acad Sci; 1958 Sep; 71(6):976-93. PubMed ID: 13583865
    [No Abstract]   [Full Text] [Related]  

  • 76. Proceedings of a symposium on significance of and progress against tumour resistance. Regensburg, FRG, 9-11th June 1983.
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():1-185. PubMed ID: 6733712
    [No Abstract]   [Full Text] [Related]  

  • 77. Passing the test.
    Heenan A
    Nurs Times; 1991 Jun 12-18; 87(24):23. PubMed ID: 2047271
    [No Abstract]   [Full Text] [Related]  

  • 78. The high, and redundant, cost of failure in cancer drug development.
    Mullard A
    Nat Rev Drug Discov; 2023 Sep; 22(9):688. PubMed ID: 37542125
    [No Abstract]   [Full Text] [Related]  

  • 79. Springing an evolutionary trap on cancer.
    Lin CY
    Nat Genet; 2020 Apr; 52(4):361-362. PubMed ID: 32246131
    [No Abstract]   [Full Text] [Related]  

  • 80. After Goldie-Coldman--where now?
    Green JA
    Eur J Cancer Clin Oncol; 1989 May; 25(5):913-6. PubMed ID: 2661241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.